[Issues of the delisting of anti-Alzheimer's drugs in France: between the law and ethics].

Going back to the delisting of drugs for Alzheimer's disease under the double prism of the jurisprudence of the State Council and from a sidestep of ethics is a requirement about the persistence of still passionate debates: the patients and their families feel abandoned, practitioners in the field distraught, and learned societies alarming the public authorities and their instances without any response to date. How the only drugs available, in responder patients, to slow down the inexorable progression of Alzheimer's disease, can finally be defunded, after three Superior Health Authority reassessments (2007, 2011, 2016) and therefore virtually removed from the therapeutic panel of physicians, while their beneficial effects, although modest on cognition, remained very actual on other symptoms such as apathy or hallucinations? How can this decision not to be understood as a signal of a disengagement from the state? How to maintain the trusting relationships between the patients, their families and caregivers, made of worry and patience?

[Ethics of consent surrounding admission to a geriatric institute].

Consent is a notion present at the heart of our nursing practice. How must we proceed when the patient has cognitive disorders impairing their judgement and ability to make decisions? In this context, consent when entering an institution raises ethical questions. Practices must be questioned and steps taken to ensure the vulnerable elderly person is part of a decision-making process which concerns them first and foremost.

The cognitive disorders examination (Codex) is a reliable 3-minute test for detection of dementia in the elderly (validation study on 323 subjects).

Background: Dementia often remains undiagnosed until it has reached moderate or severe stages, thereby preventing patients and their families from obtaining optimal care. Tools that are easy to use in primary care might facilitate earlier detection of dementia.

Aim: Develop and validate a very brief test for the detection of dementia.